(OTC: HSXI), (NYSE: MNT), (NASDAQ: NEXM), (NASDAQ: HGRD).

Turning Pennies into dollars: (OTC: HSXI), (NYSE: MNT), (NASDAQ: NEXM), (NASDAQ: HGRD).

Are you a public company looking for exposure?
Contact RealPennies.com - 1.800.940.6559

For more info: http://hsxi.realpennies.com

HealthSonix Inc. (OTC: HSXI) (February 11, 2008) announced Monday that it is has approved the final sample of its second generation enSonix medical device. Shipments of finished product are expected to commence in the second quarter.

The enSonix personal treatment device has been registered and cleared with the United States, Food and Drug Administration (FDA), and has been designated as a class1 device, the safest classification for medical devices. It has been indicated for pain reduction and muscle relaxation.

"With this new medical device, we offer our customers affordable, effective arthritis pain relief without side effects. Patients can use it in the comfort of their own homes. The enSonix therapy is especially effective when used in combination with the most popular pain relievers. There is an incremental therapeutic benefit when you combine therapies," said Dieter Doederlein, Vice President of Corporate Development. "Arthritis is still the number one cause of chronic pain in North America and the HealthSonix breakthrough medical technology is very timely as the population segment most susceptible to arthritis will double over the next 20 years." The sound pressure waves generated by the enSonix medical device are believed to work in three ways: they stimulate mechanoreceptors in the skin, which in turn communicate with the brain and block pain messages from getting through (gate control theory of pain); they create an exercise effect in the muscles, which encourages the production and release of endorphins, the body's natural pain killers; and increase in blood circulation.

"Our objective is very clear; deliver as much product this year as we can to fulfill significant order back log that has been created over the past 12 months and to focus on development and expansion of distribution and sales channels for all of our consumer products," added Mr. Doederlein.

HealthSonix, Inc. is a publicly traded research oriented medical technology company that develops and markets medical devices and healthcare products for institutional and consumer use. The company's patent pending medical devices deliver sound pressure waves to the human body for relief of pain and other musculoskeletal conditions. The focus is on arthritis, athletic injuries and conditions where acute or chronic pain is the cardinal symptom.

For more info: http://mnt.realpennies.com

Mentor Corporation (NYSE: MNT)(February 13, 2008), a leading supplier of medical products for the global aesthetic market, announced earlier today that it has recently launched an online educational resource for women considering breast augmentation and other cosmetic procedures at www.LoveYourLook.com.

The site is designed to serve as the premier and most comprehensive resource for women researching cosmetic surgery. It features a Physician Finder for U.S. only physicians, which enables visitors to locate a surgeon in their area; an interactive, personalized patient portfolio tool with 3-D imaging that enables patients to envision themselves with implants based on their specific body measurements; educational information on Mentor's MemoryGel silicone implants; and blogs and testimonials from patients who have had breast augmentation or reconstruction.

"Women who are considering breast augmentation typically do a lot of research on their own before scheduling an appointment with a doctor. We recognized the need for a single Internet site where women can get all of the information they need to make an informed decision and where they can connect with qualified physicians in their area. We designed LoveYourLook.com to be that trusted resource," said Brian Luedtke, Vice President of Marketing and Sales at Mentor Corporation.

Mentor is a leading supplier of medical products for the global aesthetic market. The Company develops, manufactures, and markets innovative, science-based products for surgical and non-surgical medical procedures that allow patients to retain a more youthful appearance and improve their quality of life. The Company's website is www.mentorcorp.com.

For more info: http://nexm.realpennies.com

NexMed, Inc. (NASDAQ: NEXM)(February 13, 2008), a developer of innovative transdermal products based on its proprietary NexACT drug delivery technology, announced earlier today that Hem Pandya, Vice President and Chief Operating Officer, will present an overview of the Company at the Roth Capital 20th Annual OC Growth Stock Conference in Laguna Niguel, CA, at 4:30 pm Pacific Standard Time on Wednesday, February 20, 2008. The conference will feature interactive presentations from more than 300 selected companies in the Media, Technology, Telecommunications, Healthcare, Consumer, Energy, and Industrial sectors, in addition to one-on-one meetings with leading institutional investors.

Interested parties may access the live webcast at http://www.wsw.com/webcast/roth16/nexm/, or on the Company's website, at http://www.nexmed.com.

NexMed, Inc. is leveraging its proprietary NexACT drug delivery technology to develop innovative topical pharmaceutical products that address unmet medical needs. NM100060, a novel onychomycosis treatment exclusively licensed to Novartis, is currently in pivotal Phase 3 trials in the U.S. and Europe. In November 2007, NexMed's New Drug Application for its alprostadil treatment for erectile dysfunction was accepted for review by the FDA and the Company signed a U.S. licensing agreement for the product with Warner Chilcott. NexMed's pipeline also includes a Phase 2 treatment for female sexual arousal disorder and an early stage treatment for psoriasis. For further information about NexMed, go to www.nexmed.com.

For more info: http://hgrd.realpennies.com

Health Grades, Inc. (NASDAQ: HGRD)(February 13, 2008) announced earlier today plans to release fourth quarter results for the period ended December 31, 2007 before the market opens on Thursday, February 21, 2008.

The Company will host a conference call, which will be broadcast live over the Internet, at 11:00 am ET/9:00 am MT that same day to discuss the results. The broadcast will be available on the Investor Relations section of the Company's website located at www.healthgrades.com. Please allow extra time prior to the call to visit the site and download the streaming media software required to listen to the Internet broadcast.

If you would like to participate on the call, please call 866-831-6272 at least ten minutes prior to the start time of 11:00 am ET/9:00 am MT on February 21, 2008 and reference the following - Confirmation number: 91158626.

An online archive of the broadcast will be available within two hours of the live call and can be accessed through March 20, 2008, by dialing 888-286-8010. The confirmation number is 39736648.

Health Grades, Inc. (NASDAQ: HGRD) is the leading healthcare ratings organization, providing ratings and profiles of hospitals, nursing homes and physicians. Millions of consumers and many of the nation's largest employers, health plans and hospitals rely on HealthGrades' independent ratings and decision support resources to make healthcare decisions based on the quality of care.

Read our full disclaimer at: http://www.realpennies.com/start.html

Investors are advised that this analysis is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy. This report does not have regard to the specific investment objectives, financial situation and the particular needs of any specific person who may receive this information. The information contained herein is based on sources that we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Past performance is no guarantee of future results. Please consult a broker before purchasing or selling any securities mentioned on RealPennies. For more movers: http://www.realpennies.com/wrapup.html

Any opinions expressed herein are statements of our judgment as of the date of publication and are subject to change without notice.
Sitemap: http://www.realpennies.com/sitemap.html

Sponsored by: http://www.isthemarketopen.com

RealPennies .

Telephone: 1-800-940-6559

Matt /at/ realpennies.com